• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毛细支气管炎临床护理路径对治疗和住院时间的影响。

Impact of a bronchiolitis clinical care pathway on treatment and hospital stay.

机构信息

Child Health Royal Aberdeen Children's Hospital, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZG, UK.

出版信息

Eur J Pediatr. 2012 May;171(5):827-32. doi: 10.1007/s00431-011-1653-9. Epub 2011 Dec 23.

DOI:10.1007/s00431-011-1653-9
PMID:22193364
Abstract

UNLABELLED

Bronchiolitis is a common lower respiratory tract infection of infancy where management has varied considerably in the past. The aim of the present study was to determine whether patient treatment and outcomes changed after introduction of a clinical care pathway. Infants aged up to 6 months admitted to hospital with bronchiolitis were identified as part of an annual audit of bronchiolitis management between winters 2003/2004 and 2009/2010. The primary outcome, duration of stay (DOS), was compared before and after the clinical pathway was introduced before the winter 2005/2006. There were 328 infants identified, mean age 75 days, respiratory syncitial virus was detected in 89%. After the clinical pathway was introduced, the proportion of infants prescribed salbutamol fell from 50% to 8% (p < 0.001) and ipratropium bromide from 38% to 0% (p < 0.001) but the proportion prescribed antibiotics was unchanged. The median DOS was 79 h prior to the clinical pathway and 66 h afterwards (p = 0.010) but there was no difference in days where supplemental oxygen or nasogastric feeding was required.

CONCLUSIONS

A clinical pathway for the management of acute bronchiolitis can be implemented in the hospital setting and the conservative approach, in particular not prescribing bronchodilators, is not associated with prolonged duration of stay.

摘要

目的

本研究旨在确定在引入临床护理路径后,患者的治疗和结局是否发生变化。

方法

在 2003/2004 年至 2009/2010 年冬季之间,对支气管肺炎管理进行年度审核期间,确定了年龄在 6 个月以下的因支气管肺炎住院的婴儿。主要结局是住院时间(DOS),并在临床路径引入之前,在 2005/2006 年冬季之前,与引入前进行比较。

结果

共确定了 328 名婴儿,平均年龄为 75 天,89%的婴儿检测到呼吸道合胞病毒。引入临床路径后,沙丁胺醇的处方比例从 50%降至 8%(p<0.001),异丙托溴铵从 38%降至 0%(p<0.001),但抗生素的处方比例不变。引入临床路径前的中位 DOS 为 79 小时,引入后为 66 小时(p=0.010),但需要补充氧气或鼻胃管喂养的天数没有差异。

结论

可以在医院环境中实施急性支气管肺炎的临床路径,保守方法,特别是不使用支气管扩张剂,与延长住院时间无关。

相似文献

1
Impact of a bronchiolitis clinical care pathway on treatment and hospital stay.毛细支气管炎临床护理路径对治疗和住院时间的影响。
Eur J Pediatr. 2012 May;171(5):827-32. doi: 10.1007/s00431-011-1653-9. Epub 2011 Dec 23.
2
A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis.一项关于雾化肾上腺素治疗急性细支气管炎婴儿的多中心、随机、双盲、对照试验。
N Engl J Med. 2003 Jul 3;349(1):27-35. doi: 10.1056/NEJMoa022226.
3
Comparison of Initial Response of Nebulized Salbutamol and Adrenaline in Infants and young Children Admitted with Acute Bronchiolitis.雾化沙丁胺醇与肾上腺素对急性细支气管炎婴幼儿初始反应的比较
Kathmandu Univ Med J (KUMJ). 2016 Jan-Mar;14(53):31-35.
4
Impact of fluctuating patterns of bronchiolitis epidemics in infants.
Eur J Pediatr. 2012 Jun;171(6):1001; author reply 1003. doi: 10.1007/s00431-012-1708-6. Epub 2012 Mar 7.
5
Variations in bronchiolitis management between five New Zealand hospitals: can we do better?新西兰五家医院间细支气管炎治疗方法的差异:我们能否做得更好?
J Paediatr Child Health. 2003 Jan-Feb;39(1):40-5. doi: 10.1046/j.1440-1754.2003.00069.x.
6
Efficacy of salbutamol and ipratropium bromide in the management of acute bronchiolitis--a clinical trial.沙丁胺醇与异丙托溴铵治疗急性细支气管炎的疗效——一项临床试验
Respiration. 2008;76(3):283-7. doi: 10.1159/000111817. Epub 2007 Nov 28.
7
Practice variation among pediatric emergency departments in the treatment of bronchiolitis.小儿急诊科在治疗细支气管炎方面的实践差异。
Acad Emerg Med. 2004 Apr;11(4):353-60. doi: 10.1197/j.aem.2003.12.003.
8
Impact of home oxygen therapy on hospital stay for infants with acute bronchiolitis.家庭氧疗对急性毛细支气管炎婴儿住院时间的影响。
Eur J Pediatr. 2012 Dec;171(12):1839-44. doi: 10.1007/s00431-012-1831-4. Epub 2012 Sep 27.
9
Racemic epinephrine compared to salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial [ISRCTN46561076].住院毛细支气管炎幼儿中消旋肾上腺素与沙丁胺醇的比较:一项随机对照临床试验 [国际标准随机对照试验编号:ISRCTN46561076]
BMC Pediatr. 2005 May 5;5(1):7. doi: 10.1186/1471-2431-5-7.
10
Acute viral bronchiolitis phenotype in response to glucocorticoid and bronchodilator treatment.急性病毒性细支气管炎表型对糖皮质激素和支气管扩张剂治疗的反应。
Clinics (Sao Paulo). 2024 Jun 5;79:100396. doi: 10.1016/j.clinsp.2024.100396. eCollection 2024.

引用本文的文献

1
Impact of bronchiolitis guidelines publication on primary care prescriptions in the Italian pediatric population.毛细支气管炎指南发布对意大利儿科人群初级保健处方的影响。
NPJ Prim Care Respir Med. 2021 Mar 19;31(1):15. doi: 10.1038/s41533-021-00228-w.
2
Impact of home oxygen therapy on hospital stay for infants with acute bronchiolitis.家庭氧疗对急性毛细支气管炎婴儿住院时间的影响。
Eur J Pediatr. 2012 Dec;171(12):1839-44. doi: 10.1007/s00431-012-1831-4. Epub 2012 Sep 27.
3
[Development of an internet-based clinical pathway exemplified by the fibromyalgia syndrome].

本文引用的文献

1
Home oxygen for children with acute bronchiolitis.急性细支气管炎患儿的家庭氧疗
Arch Dis Child. 2009 Aug;94(8):641-3. doi: 10.1136/adc.2008.144709. Epub 2008 Oct 16.
2
Nebulized hypertonic saline solution for acute bronchiolitis in infants.雾化高渗盐水溶液用于婴儿急性细支气管炎
Cochrane Database Syst Rev. 2008 Oct 8(4):CD006458. doi: 10.1002/14651858.CD006458.pub2.
3
Effect of point of care information on inpatient management of bronchiolitis.即时护理信息对毛细支气管炎住院治疗的影响。
[以纤维肌痛综合征为例的基于互联网的临床路径的开发]
Schmerz. 2012 Apr;26(2):123-30. doi: 10.1007/s00482-012-1145-5.
4
Impact of fluctuating patterns of bronchiolitis epidemics in infants.
Eur J Pediatr. 2012 Jun;171(6):1001; author reply 1003. doi: 10.1007/s00431-012-1708-6. Epub 2012 Mar 7.
BMC Pediatr. 2007 Jan 24;7:4. doi: 10.1186/1471-2431-7-4.
4
Diagnosis and management of bronchiolitis.细支气管炎的诊断与管理
Pediatrics. 2006 Oct;118(4):1774-93. doi: 10.1542/peds.2006-2223.
5
A clinical pathway for bronchiolitis is effective in reducing readmission rates.
J Pediatr. 2005 Nov;147(5):622-6. doi: 10.1016/j.jpeds.2005.06.040.
6
How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease?患有哮喘或慢性阻塞性肺疾病的临床研究患者对于更广泛的“现实生活”中阻塞性肺病患者群体有多大的代表性?
Respir Med. 2005 Jan;99(1):11-9. doi: 10.1016/j.rmed.2004.03.026.
7
How do we treat wheezing infants? Evidence or anecdote.我们如何治疗喘息的婴儿?证据还是轶事。
Arch Dis Child. 2002 Dec;87(6):546-7. doi: 10.1136/adc.87.6.546.
8
Effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness.实践变化对因病毒性下呼吸道疾病住院婴儿资源利用的影响。
Pediatrics. 2001 Oct;108(4):851-5. doi: 10.1542/peds.108.4.851.
9
Differences in management of bronchiolitis between hospitals in The Netherlands. Dutch Paediatric Respiratory Society.荷兰各医院间细支气管炎治疗方法的差异。荷兰儿科学会呼吸病学分会
Eur J Pediatr. 2000 May;159(5):343-7. doi: 10.1007/s004310051284.
10
International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group.呼吸道合胞病毒住院婴儿管理的国际差异。国际呼吸道合胞病毒研究小组。
Eur J Pediatr. 1998 Mar;157(3):215-20. doi: 10.1007/s004310050798.